Chenyu Xu Selected Research

Therapeutic Uses

1/2020

A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chenyu Xu Research Topics

Disease

9	Infections 01/2023 - 01/2013
7	Hepatitis B 06/2022 - 01/2013
2	Periodontitis 05/2024 - 04/2023
2	Ocular Hypertension (Glaucoma, Suspect) 01/2023 - 01/2020
2	Neoplasms (Cancer) 09/2022 - 12/2018
2	Ototoxicity 01/2021 - 01/2021
2	Hearing Loss (Hearing Impairment) 01/2021 - 01/2021
2	Inborn Urea Cycle Disorders 01/2020 - 03/2016
1	Dehydration (Water Stress) 01/2024
1	Inflammation (Inflammations) 04/2023
1	Body Weight (Weight, Body) 01/2023
1	Glaucoma 01/2023
1	Laryngeal Neoplasms (Laryngeal Cancer) 09/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Abdominal Aortic Aneurysm 01/2021
1	Ornithine Carbamoyltransferase Deficiency Disease 01/2020
1	Obstructive Sleep Apnea 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Breast Neoplasms (Breast Cancer) 12/2018
1	Triple Negative Breast Neoplasms 12/2018
1	Hyperammonemia 03/2016
1	Birth Weight (Birth Weights) 01/2016
1	Premature Birth (Birth, Premature) 01/2016
1	Viremia 11/2015
1	Persistent Infection 10/2013
1	Liver Diseases (Liver Disease) 10/2013
1	Hepatitis E 10/2007

Drug/Important Bio-Agent (IBA)

4	Immunoglobulins (Immunoglobulin)IBA 06/2022 - 01/2013
4	hepatitis B hyperimmune globulinIBA 06/2022 - 01/2013
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2019 - 05/2013
3	Hepatitis B e AntigensIBA 06/2022 - 01/2013
3	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 06/2022 - 12/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2013
2	PolymersIBA 05/2024 - 01/2024
2	CytokinesIBA 05/2024 - 04/2023
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2016
2	EnzymesIBA 01/2023 - 03/2016
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2016
2	Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA 01/2020 - 03/2016
2	Viral AntigensIBA 07/2018 - 11/2015
1	Coenzymes (Enzyme Cofactors)IBA 05/2024
1	Biocompatible Materials (Biomaterials)IBA 05/2024
1	LipopolysaccharidesIBA 04/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2023
1	rhodiolosideIBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	GlucosidesIBA 01/2023
1	Interleukin-33IBA 09/2022
1	InterleukinsIBA 09/2022
1	VaccinesIBA 06/2022
1	Nicotine FDA Link 01/2021
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Angiotensin IIIBA 01/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2021
1	osthol (osthole)IBA 01/2020
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 12/2018
1	LigandsIBA 12/2018

Therapy/Procedure

2	Therapeutics 01/2023 - 10/2007
1	Cesarean Section (Caesarean Section) 01/2023
1	Intraperitoneal Injections 01/2020
1	Immunotherapy 12/2018
1	Blood Transfusion (Blood Transfusions) 10/2013